Wolf K45E Manuale Utente Pagina 3

  • Scaricare
  • Aggiungi ai miei manuali
  • Stampa
  • Pagina
    / 131
  • Indice
  • SEGNALIBRI
  • Valutato. / 5. Basato su recensioni clienti
Vedere la pagina 2
III
_____________________________________________________________________________________
Inhaltsverzeichnis
Abkürzungen ...................................................................................VI
1
Einleitung
................................
................................
........
1
1.1 Einführung
................................
.............
1
1.2 Das Bartter-Syndrom (BS)
................................
....................
1
1.2.1 Übersicht
................................
................................
...........................
1
1.2.2 Pnotypische Varianten des Bartter-Syndroms
..............................
2
1.2.2.1 Hyperprostaglandin-E-Syndrom (HPS)
................................
................................
2
1.2.2.2 Klassisches Bartter-Syndrom (cBS)
................................
................................
.....
3
1.2.2.3 Gitelman-Syndrom (GS)
................................
................................
.......................
4
1.2.2.4 Bartter-Syndrom mit Taubheit (BSND)
................................
................................
.
5
1.2.3 Pathogenese
................................
................................
.....................
5
1.2.3.1 Pathogenese des Hyperprostaglandin-E-Syndroms
................................
............
6
1.2.3.2 Pathogenese des klassischen Bartter-Syndroms
................................
................
9
1.2.3.3 Pathogenese des Gitelman-Syndroms
................................
...............................
10
1.2.3.4 Pathogenese des BSND
................................
................................
.....................
11
1.3 Zielsetzung dieser Arbeit
................................
......................
12
1.3.1 Mutationsanalyse
................................
................................
............
12
1.3.1.1 Vorgehensweise
................................
................................
................................
.
12
1.3.1.2 Das ROMK-Gen (
KCNJ1
)
................................
................................
...................
13
1.3.1.3 Das ClC-Kb-Gen (
ClC-Kb
)
................................
................................
..................
15
1.3.2 Zusammenfassende Fragestellung
................................
.................
16
2
Material und Methoden
................................
.................
17
2.1 Patienten
................................
................................
..............
17
2.2 Allgemeine Materialien
................................
.........................
18
2.2.1 Geräte und Hilfsmittel
................................
................................
.....
18
2.2.2 Chemikalien und Reagenzien
................................
.........................
19
2.3 DNA-Gewinnung
................................
................................
..
20
Vedere la pagina 2
1 2 3 4 5 6 7 8 ... 130 131

Commenti su questo manuale

Nessun commento